Ietje Perfors

119 Table 1. Baseline characteristics of the study participants, intervention patients divided into groups based on TOC timing. Intervention (N = 77) TOC before treatment decision (N=11) TOC after treatment decision (N=51) No TOC (N=12) 1 Control (N = 77) Female N (%) 57 (74.0) 8 (72.7) 37 (72.5) 10 (83.3) 58 (75.3) Age mean (±SD) 61.8 (11.4) 62.4 (8.7) 61.4 (11.0) 61.3 (15.6) 59.3 (12.2) Cancer type N (%) Breast Colorectal Melanoma Lung Gynaecologic 38 (49.4) 20 (26.0) 13 (16.9) 3 (3.9) 3 (3.9) 6 (54.5) 4 (36.4) - - 1 (9.1) 24 (47.1) 14 (27.5) 9 (17.6) 3 (5.9) 1 (2.0) 8 (66.7) 2 (16.7) 2 (16.7) - - 40 (51.9) 18 (23.4) 11 (14.3) 2 (2.6) 6 (7.8) Hospital setting N (%) Academic Non academic 22 (28.6) 55 (71.4) 6 (54.5) 5 (45.5) 13 (25.5) 38 (74.5) 2 (16.7) 10 (83.3) 24 (31.2) 53 (68.8) Cancer stage 2 N (%) 0 I II III IV 2 (2.6) 34 (44.2) 22 (28.6) 18 (23.4) 1 (1.3) - 4 (36.4) 2 (18.2) 5 (45.5) - 2 (3.9) 21 (41.2) 15 (29.4) 12 (23.5) 1 (2.0) - 7 (58.3) 4 (33.3) 1 (8.3) - 2 (2.6) 34 (44.2) 27 (35.1) 14 (18.2) - Education Low Middle High 32 (41.6) 13 (16.9) 32 (41.6) 5 (45.5) 1 (9.1) 5 (45.5) 20 (39.2) 10 (19.6) 21 (41.2) 5 (41.7) 2 (16.7) 5 (41.7) 25 (32.5) 18 (23.4) 34 (44.2) Number of comorbidities (N%) None ≥1 25 (32.5) 52 (67.5) 5 (45.5) 6 (54.5) 15 (29.4) 36 (70.6) 5 (41.7) 7 (58.3) 39 (50.6) 38 (49.4) 5